REDHILL BIOPHARMA LTD. Equity
REDHILL BIOPHARMA LTD. (RDHL) had Equity of -$4.41 million as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:Equity · last filed 2025-09-05
- 2025-06-30: Equity -$4.41M.
- 2024-12-31: Equity -$4.68M.
- 2024-06-30: Equity $61.00K.
- 2023-12-31: Equity $2.07M.
| Period end | Equity |
|---|---|
| 2025-06-30 | -$4.41M 6-K · filed 2025-09-05 |
| 2024-12-31 | -$4.68M 6-K · filed 2025-09-05 |
| 2024-06-30 | $61.00K 6-K · filed 2025-09-05 |
| 2023-12-31 | $2.07M 6-K · filed 2025-09-05 |
| 2023-06-30 | $3.47M 6-K · filed 2024-08-29 |
| 2022-12-31 | -$48.40M 20-F · filed 2025-04-10 |
| 2022-06-30 | -$11.94M 6-K · filed 2023-08-17 |
| 2022-03-31 | -$8.63M 6-K · filed 2022-11-07 |
| 2021-12-31 | $8.88M 20-F · filed 2025-04-10 |
| 2021-06-30 | $29.58M 6-K · filed 2022-11-07 |
| 2021-03-31 | $53.04M 6-K · filed 2022-11-07 |
| 2020-12-31 | $13.86M 20-F · filed 2024-04-08 |
| 2020-06-30 | $34.59M 6-K · filed 2021-08-26 |
| 2020-03-31 | $43.65M 6-K · filed 2021-08-26 |
| 2019-12-31 | $60.00M 20-F · filed 2023-04-28 |
| 2019-06-30 | $31.90M 6-K · filed 2020-08-13 |
| 2019-03-31 | $41.88M 6-K · filed 2020-08-13 |
| 2018-12-31 | $51.19M 20-F · filed 2022-03-17 |
| 2018-06-30 | $25.91M 6-K · filed 2019-07-23 |
| 2018-03-31 | $36.29M 6-K · filed 2019-07-23 |
| 2017-12-31 | $45.06M 20-F · filed 2021-03-18 |
| 2017-06-30 | $48.80M 6-K · filed 2018-08-30 |
| 2017-03-31 | $58.95M 6-K · filed 2018-08-30 |
| 2016-12-31 | $62.70M 20-F · filed 2020-03-04 |
| 2015-12-31 | $60.08M 20-F · filed 2019-02-26 |
| 2014-12-31 | $25.01M 20-F · filed 2018-02-22 |